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ABSTRACT 
Objective: To develop a sensitive, fast and selective method for the determination of sumatriptan succinate (SUM) in pharmaceutical samples. 
Methods: The method is based on measuring the synchronous fluorescence of SUM using ∆λ of (12 0 nm) and at a wavelength of excitation and 
emission of 230 and 325 nm respectively, using Agilent Technology, Cary eclipse, G9800AA model Luminescence spectrometer. Effect of variables 
on fluorescence emission intensities was studied such as solvent, surfactant, and pH. The proposed method was validated in term of linearity, limit 
of detection as per the international conference on harmonization guidelines ICH Q
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(R1). 
Results: The linearity of the method was obtained with a wide range of (50-150) ng/ml with a high value of correlation coefficient value of (0.992). 
Limits of detection (LOD) and limits of quantitation (LOQ) were found to be 16.3 and 49.5 ng/ml respectively, the mean recovery was found to be 
99.1% with low relative standard deviation (% RSD). The method was also compared statistically with the reference method using t-test and f-test, 
the results show no difference either in pure or pharmaceutical tablets. 
Conclusion: The obtained results revealed that the developed method can be applied successfully for the determination of SUM in drug 
formulations samples with good accuracy and precision.  




Triptans are used for the treatment of prophyllaxis and acute migraine 
headaches in human, the most commonly used drug among triptans is 
sumatriptan succinate (fig. 1) it is chemically 3-[2-(diaminoethyl)]-N-
methyl-indole-5-methane sulfonamide succinate. sumatriptan is a 
specific and selective 5-hydroxyl tryptan receptor (5HT1D) agonist 
with no effect on other 5HT receptor (5HT2-5HT7) subtypes.  
It is official in European pharmacopeia [1] and United States 
pharmacopeia [2]. 
Several methods were suggested for the determination of 
sumatriptan in different types of samples, including, UV [3], 
spectrophotometric [4-6], other methods were based on high-
performance liquid chromatography with various detecting systems 
such as UV detection [7], fluorescence detection [8] and MS 
detection [9, 10]. Other methods were based on and voltammetry 
[11]. Few methods were based on the fabrication of nanomaterial-
based sensing methods [12-14]. According to the previous methods, 
it can be seen that most of them are based on using expensive and 
sophisticated techniques, this encourages us to develop a simple 
method for the assay of sumatriptan in the pharmaceutical samples. 
Spectrophotometric methods are widely used in the pharmaceutical 
analysis, but they have poor selectivity and sensitivity compared to 
spectrofluorimetry [15, 16]. The developed method is based on the 
enhancement of the intrinsic Fluorescence of SUM, then measuring 
Synchronous Fluorescence intensities in different media. All the 
factors affecting the fluorescence intensities were studied, including 
the type of solvent, pH, temperature and micellar additives. The 
developed methods were validated and applied to real 
pharmaceutical samples and were compared with official methods. 
Synchronous fluorescence technique has many priorities compared 
to conventional fluorescence spectroscopy, including simple spectra, 
higher selectivity, sensitivity and lower interferences which are due 
to sharper and narrower fluorescence peaks [17-19]. It is well 
known that the presence of surfactants may increase the rigidity of 
the molecules being surrounded by the surfactant which restricts 
the movement of the fluorophore and so decrease the energy 
transfer to the surrounding environment, As a result, increases the 
quantum yield and enhance the fluorescence intensity of the guest 
molecules [21, 23]. The anionic surfactant sodium lauryl sulfate 
(SLS) has recently found many applications in emission fluorescence 
enhancement and applications for the determination of some 
pharmaceutical compounds [24]. 
The developed method is considered as a low cost, a time-saving and 
sensitive method that has the advantages of not using derivatization 
reactions using toxic chemicals. Moreover, another method of the 
conventional spectrofluorimetric technique was applied using the 
synchronous scanning fluorescence at (∆λ = 120 nm), which allowed 
a simpler spectrum with less overlapping [24].  
The developed method was validated and applied successfully for 
the quantitative determination of (SUM) in pharmaceutical samples.  
 
 
Fig. 1: Chemical structure of sumatriptan succinate 
 
MATERIALS AND METHODS 
Apparatus 
Fluorescence intensities were measured using Agilent Technology, 
Cary eclipse, G9800AA model Luminescence spectrometer 
(Australia) equipped with a xenon arc lamp, The slit width for 
excitation and emission measurements were set at 5.0 nm and 
measured simultaneously with a constant ∆λ scan (λ emi-λexi) of 120 
nm. A 1.0 cm quartz cell was used at 25.0 °C. A pH meter (HANNA 
model: HI 2211) was used for all pH measurements. 
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Materials and reagents 
Reagents used were of analytical grade and deionized water was 
used throughout. Pure grade sumatriptan succinate were kindly 
supplied from Egyptian company. The pharmaceutical preparations 
were purchased from local drug stores oratab®
Aliquots of SUM standard solution were transferred into a series of 
10-ml calibrated volumetric flasks, then 1 ml of 0.2 M acetic 
acid/acetate buffer of pH (5.5) was added, followed by 0.5 ml 2% 
SLS, mixed and then diluted to the mark using methanol as a diluting 
solvent to give a final concentration of (50-150 ng/ml). Then stored 
in the refrigerator at 10 °C for 15 min, after that the Fluorescence 
intensity was measured at appropriate excitation and emission 
wavelengths corresponding to the selected diluting solvent. The 
calibration curves were constructed by plotting the fluorescence 
intensity versus SUM concentration (ng/ml) and the regression 
equations were obtained. 
100 mg tablet 
Tabouk company-Saudi Arabia. Sodium lauryl sulfate (SLS) 96 %, 
Tween 80, β-cyclodextrin, glacial Acetic acid were from BDH 
laboratory supplies, sodium acetate, sulphuric acid. Analytical grade 
solvents: acetonitrile 99.5%, methanol 99.9% dioxan 99% were 
obtained from Sharlau-Spain.  
Standard solution 
Stock solution of SUM was prepared by dissolving 0.01 g in 100 ml 
deionized water, then further dilutions were prepared using the 
given diluting solvents as appropriate and kept in the refrigerator. 
General procedures 
Calibration graphs 
Analysis of tablet samples 
The contents of ten tablets were crushed and powdered, then a mass 
equivalent to 10.0 mg was weighed and transferred into a 100 ml 
volumetric flask, about 75 ml of methanol was added, the mixture 
was sonicated for 10 min, then the volume is completed to 100 ml 
with methanol, mixed and filtered through a 0.45 µm membrane 
filter. Serial dilutions covering the working concentration range of 
(50-150 ng/ml) were transferred into a series of 10.0 ml volumetric 
flasks. Then the procedure mentioned in the preparation of 
calibration graph was followed. 
RESULTS AND DISCUSSION 
Spectrofluorimetic methods of analysis are considered as sensitive 
and simple for the determination of many pharmaceutical active 
species in different samples [25, 26]. To our knowledge there is no 
analytical method based on native fluorescence of SUM, in this study, 
it was found that SUM exhibits an emission fluorescence spectrum at 
about 350 nm after excitation at 225 nm in aqueous medium (fig. 2) 
So there is a need to investigate the effect of different media on such 
behavior, because of its relatively low relative fluorescence intensity 
(RFI). It is important to develop a simple and sensitive 
spectrofluorimetric method for the determination of SUM in a 
different type of samples. In this study, various experimental factors 
that influence the RFI of SUM were studied in order to decrease the 
detection limit. So different factors were studied as follow: 
  
 
Fig. 2: Fluorescence spectra of SUM (100 ng/ml) in 10.0 ml of water (A) and methanol (B) 
 
Effect of diluting solvent 
In order to study the effect of different media on the enhancement of 
fluorescence intensity, different organic solvents were used as 
diluting solvents including acetonitrile, methanol, ethanol, and 
dioxan. It was found that the fluorescence intensity is enhanced with 
the order of methanol, acetonitrile, dioxan and then ethanol as can 
be seen in (fig. 3). This behavior is probably due to the dynamic 
stabilization of the studied drug. The emission wavelengths of SUM 
in dioxan were 275 and 350 for acetonitrile and 294 nm for 
methanol. The excitation wavelength were 298, 262 nm and 253 nm 
of the three solvents respectively. 
 
 
Fig. 3: Effect of diluting solvent on RFI of 10.0 ml solution of SUM (100 ng/ml), error bars represent the standard deviation of three 
experiments 
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Effect of organized media 
For the better enhancement of the analytical characteristics of the 
fluorescence spectra of SUM, a study of the effect of different types 
of surfactants (cationic, anionic and nonionic) and beta-cyclodextrin 
was performed using the different effect of equal volume each 
surfactant used were summarized in (fig. 4), it can be shown that 
SLS gave the best enhancement of the RFI which is due to the 





Fig. 4: Effect of the addition of organized media on RFI of SUM (100 ng/ml), 10.0 ml sample, after the addition of 1 ml of 0.5% of each 
medium of the RFI of SUM. Error bars represent the standard deviation of three experiments 
 
Effect of pH 
The effect of pH values on the fluorescence intensity was studied by 
using different values of pH prepared by different buffer solutions 
with methanol as a diluting solvent and SLS surfactant, it was found 
that the maximum value of fluorescence intensity was obtained at 
pH around 5 using acetate buffer as shown in (fig. 5), which is 
probably due to the formation of a non-ionizable form of the studied 
drug at this pH value. 
 
 
Fig. 5: Effect of pH on RFI of SUM (100 ng/ml) using acetate buffer, error bars represent the standard deviation of three experiments 
 
In order to minimize the broadening of the emission fluorescence 
peaks and thus possible overlapping and minimize scattering. An 
alternative method for the conventional fluorescence spectrum is 
the use of synchronous scanning fluorescence. In this technique, the 
excitation and emission monochromator were scanned 
simultaneously and the emission intensity is recorded as a function 
of the excitation wavelengths. The difference between λem. and λex. 
A linear relationship was established for SUM by plotting relative 
fluorescence intensities against different drug concentrations, the 
calibration curve was linear over the range 50-150 ng/ml with a 
high value of correlation coefficient (r) table 1. 
 
(∆λ) is a very important factor in the synchronous spectrum for 
determining the position of the bands and their intensities. In the 
present work the optimization of (∆λ) was performed by selecting 
different values of (∆λ) then interpretation of the fluorescence 
spectrum, as a result, ∆λ=120 nm was selected because it gave 
sharper peak with maximum intensity, least peak overlap and 
increase in (RFI) as a function of concentration of SUM as shown in 
(fig. 6) below. 
Validation of the proposed method 
The developed method was validated using the following 
parameters: Linearity, sensitivity, LOD, LOQ, specificity, accuracy 
and precision. 
Linearity and range 
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Fig. 6: Calibration of SUM using the proposed synchronous method using, (∆λ= 120 nm) in methanol with SLS added, the concentration 
range is (50-150 ng/ml) 
 
Limit of detection (LOD) and limit of Quantitation (LOQ) 
LOD and LOQ were calculated according to ICH Q2 (R1
LOD = 3.3 Sa/b 
) 
recommendations [ICH Expert Working Group. ICH harmonized 
tripartite guidelines. Validation of Analytical procedures: text and 
methodology [28], using the following equations and the results are 
shown in table 1 
LOD = 10 Sa/b  
Where Sa: standard deviation of the intercept and Sb: standard 
deviation of the slope of the calibration curve. 
Validation of the developed spectrofluorimetric methods 
 
Table 1: Analytical Performance data of the proposed method 
Parameter SUM 
Synchronous scanning range (nm) 200-300 
∆λ (nm) 120 
Linearity range (ng/ml) 50-150 
Correlation coefficient 0.992 
Slope (b) 0.939 
Intercept (a) 68.4 
SD of the intercept (Sa) 4.65 
SD of the slope (Sb) 0.0021 
% RSD 1.3 a 
LODb 16.3  (ng/ml) 
LOQc 49.5  (ng/ml) 
aPercent relative standard deviation of three replicate samples, bLimit of detection, c
 
Accuracy and precision 
Limit of quantitation 
To investigate the accuracy and precision of the developed method, 
the assay results of SUM were compared from standard reference 
method [28], statistical analysis of the results using student’s t-test 
and variance ratio F-test [30] showed no significant differences 
between the performance of the proposed method and reference 
method regarding accuracy and precision (table 2) 
  
Table 2: Assay results of the proposed method for SUM in pure and tablet forms compared with a reference method 
Parameter:  Proposed method % Found Reference method % Found 
 Amount Amount  Amount Amount   
 taken found  taken found  
 (ng/ml) (ng/ml)  (ng/ml) (ng/ml)  
 5.0 4.974 99.48 5.0 4.910 99.20  
 10.0 9.876 98.60 10.0 10.074 100.27 
 20.0 20.143 100.7 20.0 19.948 99.74 
 50.0 49.651 99.30 50.0 50.204 100.41 
*x̅±SD   99.52±0.87   99.82±0.61 
t-value 0.32      
F-value 0.57      
Oratab  ®      
100 mg tablet  20.0 19.93 99.6 20.0 20.07 100.4  
 40.0 39.76 99.4 40.0 39.89 99.7 
 60.0 58.85 98.3 60.0 59.87 99.8 
*x̅±SD 99.1±0.7   99.9±0.38  
t-value 0.065 (3.18)     
F-value 0.450 (9.55)     
*mean±SD, (SD)-standard deviation, n=3, Numbers in the parentheses are the critical tabulated values of t and F at (P=0.05) 
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Table 3: Intra-assay and inter-assay precision and accuracy of the determination of SUM in tablets using the proposed method 
 Intra-assay Inter-assay 
 Nominal conc Measured conc. Recovery conc Nominal  Measured conc. Recoverya  
 (ng/ml) (ng/ml) (%±RSD) (ng/ml) (ng/ml) (%±RSD)  
 50 50.23 100.5 50 49.65 99.3 
 100 99.68 99.7 100 97.86 97.9  
 150 149.57 99.7 150 147.83 98.6 
a
x̅±SD 




The developed method was successfully applied for the intra-day 
and inter-day determining (SUM) in its drug tablets on three 
successive days, the recovery results were obtained for the assay of 
SUM in pharmaceutical tablets as shown in (table 3). The results 
were comparable with those obtained from the reference method. 
CONCLUSION 
In this study, a new nonexpensive and sensitive procedure was 
developed for the determination of sumatriptan succinate based on 
the enhancement of native fluorescence of the studied drug using 
methanol as solvent and sodium lauryl sulfate as a micellar medium. 
The new method utilized the use of synchronous scanning for the 
determination of SUM in both pharmaceutical tablets, the method 
was validated and compared with reference methods. 
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